¾Ã²Ý¸£Àû

All publications

Journal articles

• Harnan S, Navega Biz A, Hamilton J, Whyte S, Simpson E, Ren S, Cooper K, Clowes M, Abulafi M, Ball A , Benton SC et al (2025) . Health Technology Assessment, 29(46).
• Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L , Wilcox M et al (2025) . Applied Health Economics and Health Policy, 23(4), 753-754.
• Cooper K, Nalbant G, Essat M, Harnan S, Wong R, Hamilton J, Asghar US, Battisti NML, Wyld L & Tappenden P (2025) . Breast Cancer Research and Treatment, 210(2), 229-247.
• Harnan S, Hamilton J, Simpson E, Clowes M, Navega Biz A, Whyte S, Ren S, Cooper K, Abulafi M, Ball A , Beton S et al (2025) . Colorectal Disease, 27(1).
• Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L , Wilcox M et al (2025) . Applied Health Economics and Health Policy, 23(1), 5-17.
• Harnan S, Hamilton J, Simpson E, Clowes M, Biz AN, Whyte S, Ren S, Cooper K, Ball A, Benton S , Carten R et al (2024) . International Journal of Technology Assessment in Health Care, 40(S1), S56-S57.
• Biz AN, Stevenson M, Whyte S, Hamilton J, Ren S, Heathcote L, Simpson E, Cooper K, Clowes M, Ball A , Benton S et al (2024) . International Journal of Technology Assessment in Health Care, 40(S1), S7-S7.
• Harnan S, Hamilton J, Simpson E, Clowes M, Biz AN, Whyte S, Ren K, Cooper K, Abulafi M, Ball A , Benton S et al (2024) . Value in Health, 27(12).
• Harnan S, Gittus M, Falzon L, Durkie M, Mandrik L, Ong AC & Fotheringham J (2024) . Value in Health, 27(12), S493-S493.
• Harnan S, Kearns B, Scope A, Schmitt L, Jankovic D, Hamilton J, Srivastava T, Hill H, Ku CC, Ren S , Rothery C et al (2024) . Health Technology Assessment, 28(73).
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A (2024) . International Journal of Neonatal Screening, 10(3).
• Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, McNeill A & Bessey A (2024) . International Journal of Neonatal Screening, 10(3).
• Woods B, Schmitt L, Jankovic D, Kearns B, Scope A, Ren S, Srivastava T, Ku CC, Hamilton J, Rothery C , Bojke L et al (2024) . Health Technology Assessment, 28(28), 1-238.
• Cooper K, Campbell F, Harnan S & Sutton A (2023) . Comprehensive Psychoneuroendocrinology, 16.
• Poku E, Cooper K, Cantrell A, Harnan S, Sin MA, Zanuzdana A & Hoffman A (2023) . JAC-Antimicrobial Resistance, 5(1).
• Rafia R, Martyn-St James M, Harnan S, Metry A, Hamilton J & Wailoo A (2022) . Value in Health, 25(5), 761-769.
• Poku E, Harnan S, Rooney G, James MM-S, Hernandez M, Schaufler T, Thokala P & Fotheringham J (2022) . Clinical Kidney Journal, 15(3), 484-499.
• Phang Romero Casas C, Martyn-St James M, Hamilton J, Marinho DS, Castro R & Harnan S (2022) . BMJ Open, 8(2).
• Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . American Journal of Kidney Diseases, 76(4), 521-532.
• Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR & Eastell R (2020) . Bone, 137.
• Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR & Eastell R (2020) . Bone, 132.
• Harnan S, Tappenden P, Cooper K, Stevens J, Bessey A, Rafia R, Ward S, Wong R, Stein RC & Brown J (2019) . Health Technology Assessment, 23(30), 1-328.
• Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) . Applied Health Economics and Health Policy, 17(3), 295-313.
• Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y & Cutting R (2018) . Pharmacoeconomics, 36(10), 1143-1151.
• Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T & Saha S (2018) . Pharmacoeconomics, 36, 131-144.
• Harnan SE, Essat M, Gomersall T, Tappenden P, Pavord I, Everard M & Lawson R (2017) . Clinical and Experimental Allergy, 47(3), 410-429.
• Tappenden P, Harnan S, Ren S, Thokala P, Wong R, Mukuria C, Green C, Pledge S & Tidy J (2016) . PharmacoEconomics.
• Rafia R, Scope A, Harnan S, Stevens JW, Stevenson M & Lobo A (2016) . PharmacoEconomics.
• Uttley L, Whiteman BL, Woods HB, Harnan S, Philips ST & Cree IA (2016) . EBioMedicine.
• Gomersal T, Harnan S, Essat M, Tappenden P, Wong R, Lawson R, Pavord I & Everard ML (2016) . Pediatric Pulmonology, 51(3), 316-328.
• Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, Lawson R & Everard M (2016) . European Respiratory Society.
• Pickering A, Harnan S, Cooper K, Sutton A, Mason S & Nicholl J (2016) . Journal of Health Services Research and Policy, 21(1), 51-60.
• Harnan SE, Cooper K, Jones SL & Jones E (2015) . Evidence and Policy, 11(4), 589-601.
• Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, Pavord I, Everard M & Lawson R (2015) . Health Technology Assessment, 19(82).
• Pickering A, Cooper K, Harnan S, Sutton A, Mason S & Nicholl J (2015) . Journal of Trauma and Acute Care Surgery, 78(1), 164-177.
• Whyte S & Harnan S (2014) . Cancer Causes Control, 25(6), 647-658.
• Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G & O'Donnell ME (2014) . Angiology, 65(3), 190-197.
• Tappenden P, Harnan S, Uttley L, Mildred M, Walshaw M, Taylor C & Brownlee K (2014) . PHARMACOECONOMICS, 32(2), 159-172.
• Tappenden P, Harnan S, Uttley L, Mildred M, Carroll C & Cantrell A (2013) . Health Technol Assess, 17(56), v-181.
• Uttley L, Harnan S, Cantrell A, Taylor C, Walshaw M, Brownlee K & Tappenden P (2013) . Eur Respir Rev, 22(130), 476-486.
• Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J & Stansby G (2013) . Br J Surg, 100(13), 1838-1839.
• Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P & Wyld L (2013) . Health Technol Assess, 17(44), 1-302.
• Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J & Stansby G (2012) . British Journal of Surgery, 99(12), 1630-1638.
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A (2012) . J Neurotrauma, 29(5), 707-718.
• Squires H, Simpson E, Meng Y, Harnan S, Stevens JW, Wong R, Thomas S, Michaels J & Stansby G (2011) . Health Technology Assessment, 15(40).
• Harnan SE, Cooper KL, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Ingram C, Lorenz E, Wilkinson ID & Wyld L (2011) . Eur J Surg Oncol, 37(11), 928-936.
• Pickering A, Goodacre S, Pandor A, Harnan S, Holmes M & Fitzgerald P (2011) . Journal of Paramedic Practice, 3(8), 418-423.
• Pandor A, Goodacre S, Harnan S, Holmes M, Pickering A, Fitzgerald P, Rees A & Stevenson M (2011) . Health Technol Assess, 15(27), 1-202.
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) . J Trauma, 71(1), 245-251.
• Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID & Lorenz E (2011) . Eur J Surg Oncol, 37(3), 187-198.
• Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID & Lorenz E (2011) . Health Technol Assess, 15(4), iii-134.
• Pickering A, Harnan S, Fitzgerald P, Pandor A & Goodacre S (2011) . Archives of Disease in Childhood, 96(5), 414-421.
• Meng Y, Ward S, Cooper K, Harnan S & Wyld L (2011) . Eur J Surg Oncol, 37(1), 40-46.
• Cree I, Uttley L, Woods HB, Kikuchi H, Reiman A, Harnan S, Whiteman BL, Philips ST, Messenger M, Cox A , Teare D et al () . BMC Cancer, 17.
• Harnan S, Ren S, Gomersall T, Everson-Hock ES, Sutton A, Dhanasiri S & Kulasekararaj A () . Acta Haematologica, 136(1), 23-42.

Conference proceedings

• Harnan S, Gittus M, Falzon L, Durkie M, Mandrik O, Ong A & Fotheringham J (2025) . Clinical Kidney Journal, Vol. 18(7)
• Vilaca T, Schini M, Harnan S, Poku E, Cummings SR & Eastell R (2020) . Journal of the Endocrine Society, Vol. 4(Supplement_1). San Francisco, CA, USA, 28 March 2020 - 31 March 2020.
• Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings S & Eastell R (2020) THE RISK OF HIP AND NON-VERTEBRAL FRACTURES IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S55-S55)
• Schini M, Vilaca T, Eastell R, Harnan S, Sutton A, Poku E & Cummings S (2019) The Risk of Hip and Non-Vertebral Fractures in Parkinson's Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 103-103)
• Vilaca T, Salam S, Eastell R, Schini M, Harnan S, Sutton A, Poku E & Cummings S (2019) The Risk of Hip and Non-Vertebral Fractures in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 25-25)
• Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I & Everard M (2015) . Value in Health, Vol. 18(7) (pp A345-A345)
• Harnan S, Ren S, Gomersall T, Everson-Hock E, Sutton A, Dhanasiri S & Kulasekararaj A (2014) . Blood, Vol. 124(21) (pp 1934-1934)
• Tappenden P, Harnan S, Uttley L, Mildred M, Taylor CJ, Brownlee K & Walshaw M (2013) . Value in Health, Vol. 16(7) (pp A372-A372)
• Harnan SE, Uttley L, Cantrell A, Taylor CJ, Walshaw M, Brownlee K & Tappenden P (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A367-A367)
• Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G & O'Donnell M (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A633-A633)
• Pandor A, Harnan SE, Goodacre SW, Pickering A, Fitzgerald P & Rees AC (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A245-A245)
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• Harnan SE, Jorgensen A, Tsuchiya A, Goyder L & Woods HB (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A343-A343)
• Pickering A, Fitzgerald P, Harnan SE, Pandor A & Goodacre SW (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• White S, Mason S, Parker A, Harnan S, Davis B, ChessWilliams R & Woolf A (1997) alpha(1B)-adrenoceptor affinity and density differentiated and undifferentiated mouse glomerular mesangial cells.. J AM SOC NEPHROL, Vol. 8 (pp A1432-A1432)
• BLEAKMAN D, PEARSON K, HARNAN S, KAMBOJ R & SCHOEPP D (1995) EFFECTS OF LY293558 AND NBQX ON GLUTAMATE-RECEPTOR RESPONSES IN RAT CEREBELLAR PURKINJE NEURONS AND HEK293 CELLS EXPRESSING THE HUMAN GLUR6 GLUTAMATE-RECEPTOR. BRIT J PHARMACOL, Vol. 115 (pp P112-P112)

Reports

• Leaviss J, Harnan S, Pandor A & Cantrell A (2022) Newborn screening for congenital adrenal hyperplasia. External review against programme appraisal criteria for the UK National Screening Committee
• Harnan S, Kearns B, Scope A, Schmitt1 L, Jankovic1 D, Hamilton J, Wong R, Srivastava T, Hill H, Chang Ku C , Ren K et al (2021) Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.

Posters

• Pickering A, Harnan S, Pandor A, Fitzgerald P & Goodacre S (2010) Clinical Decision Rules for children with minor head injury: A systematic review. European Society of Emergency Medicine,(EuSEM) Stockholm.
• Pickering A, Harnan S & Goodacre S Diagnostic accuracy of individual characteristics following minor head injury in children: A systematic review.
• Pickering A, Harnan S, Pandor A & Goodacre S A systematic review of Clinical Decision Rules in the management of adult minor head injury.
• Carroll C, Papaioannou D & Harnan S Surgical interventions for the primary prophylaxis of retinal detachment in Stickler Syndrome: a systematic review.
• Harnan S, Cooper K, Meng Y, Ward S, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson I & Lorenz E Magnetic resonance imaging (MRI) for assessment of axillary lymph node metastases in breast cancer: systematic review.
• Harnan S, Pickering A, Pandor A & Goodacre S Clinical decision rules for adults with minor head injury: a systematic review.
• Harnan S, Jorgensen A, Tsuchiya A, Goyder E & Woods H Towards cost-effectiveness analysis of the health and wellbeing benefits of urban green space: a mapping review.
• Pickering A, Fitzgerald P, Harnan S, Pandor A & Goodacre S The role of biochemical markers in the identification of intracranial pathology following minor head injury: a systematic review and meta-analysis.
• Pandor A, Harnan S, Goodacre S, Pickering A & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
• Pickering A, Harnan S, Pandor A & Goodacre S Clinical Decision Rules for children with minor head injury: A systematic review.
• Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I & Everard M Exhaled nitric oxide for the diagnosis of asthma in children and adults: a systematic review.
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.